WHO Prequalifies First Monoclonal Antibody Tocilizumab to Treat Covid-19
Tocilizumab given intravenously has been shown in clinical studies to reduce death in certain patients with Covid-19 who are severely
Read more
Tocilizumab
WHO Reports Shortage of Covid Treatment Medicine
WHO and Unitaid are concerned by pharmaceuticals company Roche’s statement, warning of a global shortage of tocilizumab (brand name Actemra/RoActemra),
Read more